Illinois Medicaid and tirzepatide
Zepbound for weight loss: no. Non-preferred. Covered for obstructive sleep apnea with prior authorization. Mounjaro for weight loss: no; for type 2 diabetes Illinois Medicaid must cover it. Read from Illinois Department of Healthcare and Family Services documents Nov 6, 2026.
In 2025 Illinois Medicaid paid for 36,372 tirzepatide prescriptions (Mounjaro, Zepbound), 13% of its GLP-1 prescriptions and 17th of the 50 states and DC. It reimbursed $39.2 million before rebates, $1,079 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 34,435 | $37.2 million | $1,081 |
| Zepbound | 1,937 | $2.0 million | $1,049 |
Illinois plans and prescribing rules
Illinois State Employees Group Insurance Program. Illinois state employee plans cover medically necessary injectable medication for weight loss for adults with prediabetes, gestational diabetes or obesity, under state law. After the first prescription the member must enroll in, and stay in, a lifestyle management program or coverage is denied.
Blue Cross and Blue Shield of Illinois. Blue Cross and Blue Shield of Illinois treats GLP-1 weight-management coverage as an optional choice for employer groups. From November 1, 2026, self-funded groups with Prime Therapeutics that cover these drugs can set a $150 member cost share for up to a 30-day supply.
Tirzepatide in the states around Illinois
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Illinois | 17 | $69/moWellmedr | 36,372 | Medicaid Zepbound: No |
| Indiana | 17 | $69/moWellmedr | 19,161 | Medicaid Zepbound: No |
| Iowa | 17 | $69/moWellmedr | 22,499 | Medicaid Zepbound: No |
| Kentucky | 17 | $69/moWellmedr | 66,258 | Medicaid Zepbound: No |
| Missouri | 16 | $69/moWellmedr | 127,722 | Medicaid Zepbound: Yes |
| Wisconsin | 17 | $69/moWellmedr | 118,120 | Medicaid Zepbound: Yes |



